COVID-19 (+) patient LEVs, demonstrates significantly greater CD41 (platelet) expression (MFI) compared to healthy donor SEVs (p = 0.0004) and LEVs (p = 0.0006) as well as SEV (p = 0.00004) from COVID-19 (+) patient plasmas (Fig. S5D). This evidence concerns the gene ITGA2B and COVID-19.